January 22, 2025 - 18:53

In a recent directive, acting health secretary Dorothy Fink has instructed federal health agencies to suspend most public communications until February 1. This memo, which has drawn significant attention, mandates that staff members must obtain explicit approval from a presidential appointee before engaging in any external dialogue regarding agency matters.
This move is seen as a significant shift in how health agencies interact with the public and media, raising concerns about transparency and communication during a critical time for public health. Employees are now faced with stringent limitations on sharing information, which could impact the dissemination of important health updates and guidance.
Critics argue that such restrictions could hinder the public's access to vital information, especially in the context of ongoing health challenges. As the agencies navigate this new communication landscape, the implications for public trust and engagement remain to be seen. The directive highlights the ongoing tension between governmental oversight and the need for open communication in public health.
June 10, 2026 - 04:29
Spring Jogging: A Doctor's Guide to Avoiding Common InjuriesAs the weather warms up, many people lace up their running shoes for the first time in months - or for the first time ever. But jumping into jogging without proper preparation can lead to painful...
June 9, 2026 - 13:12
Highly effective prevention drug arrives in South Africa, which has world’s highest HIV burdenSouth Africa has begun distributing lenacapavir, a new injectable drug that provides six months of protection against HIV. President Cyril Ramaphosa called the arrival of the medication a major...
June 8, 2026 - 23:35
How the CDC is building the data infrastructure U.S. public health needsThe Centers for Disease Control and Prevention is quietly rebuilding the nation`s public health data infrastructure from the ground up. Through its Office of Public Health Data, Surveillance and...
June 8, 2026 - 06:10
$2 million gene therapy cures require a financing modelA new generation of gene therapies can cure devastating diseases in a single dose, but their price tags of two million dollars or more are creating a crisis in healthcare financing. William Padula,...